Events

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will speak at the "Artificial Intelligence in BioPharma" breakfast briefing organized by ai|week and BioLIVE. The panel will explore the role artificial intelligence can play in improving efficiencies and processes for drug development and manufacturing across the biopharma industry. Panelists include Dr. Ajit Narang, Lead Scientist at Genentech, and Dr. Jeffrey Hemenway, Lead Scientist – Formulation & Process Development at Gilead Sciences.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will present on the panel of "Trailblazers From the Digital Frontier" at the Digital Health Summit @ CES 2018. The Digital Health Summit provides a unique look at the role of technology in advancing modern medicine, healthcare and wellness. With advances in precision medicine, mobile, AI and deep machine learning, plus new devices quantifying our health, we’re poised for great transformation. It's both a business opportunity and world imperative.

Brian Dolan, Deep 6 AI's co-founder and chief scientist, will join the "Thinking Machines Mean Business" panel at the USC Innovation Coast Conference.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will join the "Accelerating Innovation at Cedars-Sinai" panel at The Cedars-Sinai Accelerator powered by Techstars & SoCal HIMSS Innovation Dinner.

This event is invite-only with limited seating, but will be livestreamed. Join us for an intriguing discussion of innovation, new technology, and leading ways to improve patient care with two exhilarating panels of individuals leading you into the next generation of healthcare practices.

 
Wout Brusselaers, Deep 6 AI's CEO and co-founder, will join the "AI and Clinical Care" panel at the UCLA Anderson Healthcare Conference 2018.

The UCLA Anderson Healthcare Conference brings together powerful speakers and panelists across healthcare domains — including payer, provider, biopharma, medtech, digital health and beyond — as they share their thoughts on recent developments and visions of how the healthcare landscape will change in the coming years.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will co-present "Finding the ROI of AI" with Bobbie J. Rimel, MD of Cedars-Sinai Medical Center at HIMSS18. You can also find Deep 6 AI in the HIMSS18 Innovation Live area in the Cedars-Sinai Accelerator powered by Techstars booth.

The 2018 HIMSS Conference & Exhibition, March 5-9, 2018, brings together 40,000+ healthcare IT professionals, clinicians, executives and vendors from around the world.

Wout Brusselaers, Deep 6 AI's co-founder and CEO, will speak at the Connect to End Cancer event at SXSW in "Connect to End Cancer, Session 1."

The University of Texas MD Anderson Cancer Center, the AT&T Connected Health Foundry, and Merck & Co., Inc. strive to find new approaches to applying digital health technology to advance clinical care, advance clinical research, and improve the patient experience. They launched Connect to End Cancer at the 2017 SXSW Interactive Festival and will host the second annual event in 2018.

Wout Brusselaers will give a 20-minute presentation as part of the sold-out Big Data, Austin event organized by Data Natives. The evening will feature exciting talks from data science industry leaders and experts, followed by beers, pizza, and networking.

Wout Brusselaers will speak on the panel of "Myths, Good Bets, and Realities: Breaking the Health Digital Deadlock through Big Data and AI" at SXSW.

Big Data and AI are buzzwords when it comes to healthcare future. From public health, to personal patient data and transparency of medical documentation, to care personalization, to the future of work for clinicians, the expectations on Big Data impact are at times astonishing and at times alarming. On the other hand, the collaboration between Healthcare providers, start-ups and tech companies, each with its complementary set of capabilities, is uniquely positioned to seize the opportunity big data promises. This panel will look at how to cross the Health Big Data chasm and accelerate the pathways to digital transformation as well as how big data will impact existing business models within the healthcare ecosystem.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will present as part of the "Creating Synergies Between Health Care and Clinical Trial Data Through Technology" session at the Bridging Clinical Research & Clinical Health Care Conference.

Poor recruitment is the leading cause of clinical trial failure. Less than 3% of patients and physicians participate. The Bridging Clinical Research & Clinical Health Care Collaborative is committed to getting another 3% of patients and physicians involved — a small increase that would have an enormous impact on clinical trials and the future of health care.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will present a plenary session on how artificial intelligence accelerates patient recruitment for clinical trials at the Canada Talks Pharma conference.

Canada Talks Pharma brings together professionals from pharma, biotech, medical device companies, CROs, SMOs, hospitals, Health Canada, the FDA and other government stakeholders to profile innovative ideas and new technologies in clinical research and participate in thoughtful discussions in research, policies, and international regulations.

Wout Brusselaers, CEO of Deep 6 AI, will speak at MAGI’s Clinical Research Conference - 2018 East as part of the (W858b) Master Class: Patient Recruiting & Retention workshop. Wout will discuss challenges associated with recruiting patients for clinical trials using EHR data.

MAGI is streamlining clinical research by standardizing best practices for clinical research operations, business and regulatory compliance. Its 10,000+ members represent clinical research sponsors, sites and CROs. MAGI's Clinical Research Conference - 2017 West offers 100+ sessions and workshops in six tracks - clinical operations and project management, site management, contracts, budgets & billing, regulatory compliance, and special topics - with 22+ contact hours available for CME, CNE, CLE, CCB and other credits.

Deep 6 AI will present "The High ROI of Using Artificial Intelligence for Clinical Trials Recruitment" at DIA 2018.

DIA 2018 Global Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies.

Wout Brusselaers, Deep 6 AI's CEO and co-founder, will join the "Practical Applications of AI in Cancer" panel at the MedCity CONVERGE Conference.

MedCity CONVERGE is a two-day executive summit that gathers thought leaders from across all healthcare sectors to provide actionable insight on where oncology innovation is heading. Technology disruptors, payers, providers, life science companies, venture capitalists and more will gather to discuss how AI, big data, and precision medicine are changing the game in cancer.

Wout Brusselaers, Deep 6 AI's CEO, will present on "The High ROI of Using AI for Clinical Trials " as part of the healthcare track at "SoCal AI & Data Science Conference 2018".

SoCal Data Science Conference is a data science learning platform to connect data science enthusiasts organized by IDEAS - International Data Engineering And Science Association. The conference demonstrates cutting-edge technology and features a variety of data science experts covering topics including industry trends, data science application, open-source software, machine learning and many others.

Wout Brusselaers, CEO of Deep 6 AI, will speak at MAGI’s Clinical Research Conference - 2018 West as part of the (D543) Innovative Methods for Assessing Protocol Feasibility panel. Wout will discuss protocol feasibility assessment - doing it right the first time.

MAGI is streamlining clinical research by standardizing best practices for clinical research operations, business and regulatory compliance. Its 10,000+ members represent clinical research sponsors, sites and CROs. MAGI's Clinical Research Conference - 2018 West offers 100+ sessions and workshops in six tracks - clinical operations & project management, site management, regulatory compliance, contracts, budgets & billing, and special topics - with 22+ contact hours available for CME, CNE, CLE, CCB and other credits.

October 25-26

Join our CEO Wout Brusselaers, as he participates in the panel discussion: "Patient Selection, Recruitment & Retention” at this year's AI Applications Summit Biopharma. The discussion will delve into how innovative uses of AI improves results in the feasibility of your study to save you time and money by finding the right patients quickly.

Track: Patient Selection, Recruitment & Retention
Speaker: Wout Brusselaers, CEO and Co-founder
Location: Joseph B. Martin Conference Center at Harvard Medical School
Date and Time: Thursday, October 25, 2018 at 3:20 PM ET

Add to Calendar